LCN2 and type 2 diabetes mellitus: A prospective cohort study on type 2 diabetes patients with advanced nephropathy showed that patients in the highest quartile of urinary NGAL had a higher risk of reaching a composite outcome, including a rapid eGFR decline and ESKD, during a follow-up of 3 years [36].